NCT04103112

Brief Summary

Patients with a deep vein thrombosis (DVT) may develop long-term symptoms, e.g. lifelong leg pain, skin changes and occasionally ulceration, known as post-thrombotic syndrome (PTS). This affects about half of people with a history of DVT. This randomised study aims to show whether the regular use of a compression stocking after DVT in the leg, prevents long-term pain, swelling and ulceration. Currently small trials show varied results and a large trial is required to answer the question.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
152

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2020

Typical duration for not_applicable

Geographic Reach
1 country

12 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 19, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 25, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

March 5, 2020

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

March 7, 2024

Completed
Last Updated

March 7, 2024

Status Verified

July 1, 2023

Enrollment Period

2.8 years

First QC Date

September 19, 2019

Results QC Date

July 21, 2023

Last Update Submit

July 21, 2023

Conditions

Keywords

Deep Vein Thrombosis

Outcome Measures

Primary Outcomes (1)

  • Incidence of Post Thrombotic Syndrome (PTS)

    Measured using the validated Villalta criteria

    30 months

Secondary Outcomes (6)

  • Venous Ulceration Incidence

    30 months

  • Employment Status

    30 months

  • Change in Disease-specific and Generic Quality of Life

    18 months

  • Change in Disease-specific and Generic Quality of Life

    18 months

  • The Proportion of Participants Who Are Adherent to Stockings and Anticoagulants

    30 months

  • +1 more secondary outcomes

Study Arms (2)

Standard clinical care

NO INTERVENTION

Standard clinical care (anticoagulation) with no graduated compression stocking

Graduated compression stocking and standard clinical care

EXPERIMENTAL

A graduated compression stocking and the standard clinical care (anticoagulation)

Device: Graduated compression stocking

Interventions

Compression stockings have been used safely in the UK for about 50 years. They contain an elastic fibre designed to fit tightly around the legs. These specialist stockings are tighter around the ankle, with the level of compression gradually decreasing up the garment. The pressure created by the stockings helps blood flow up the leg, allowing blood to flow freely to the heart and not pool in the leg which can result in pain and swelling.

Graduated compression stocking and standard clinical care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Symptomatic presentation of first deep vein thrombosis, \<2 weeks from diagnosis
  • Imaging confirmed, lower limb deep vein thrombosis (popliteal, femoral, iliac or combination)
  • Ability to give informed consent
  • Age 18 or over

You may not qualify if:

  • Life expectancy \< 2 years
  • Contraindication to wearing graduated compression stockings
  • Previously intolerant of or already wearing graduated compression stockings for more than 1 month.
  • Ankle brachial pressure index (ABPI) \<0.8 or pedal pulses absent
  • Bilateral deep vein thrombosis
  • Previous chronic venous insufficiency (patients with existing chronic skin changes or ulceration, defined as C4,5,6 by Clinical Etiological Anatomical Pathophysiological (CEAP) classification)
  • Pre-existing post thrombotic syndrome, significant leg pain (e.g. knee arthritis, spinal claudication) or oedema (e.g. lymphoedema).
  • Newly diagnosed cancer, metastatic cancer, or cancer undergoing active treatment or palliation
  • Contraindication to anticoagulation
  • Known allergy to fabric in compression stockings

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (12)

Basildon and Thurrock University Hospitals NHS Foundation Trust

Basildon, United Kingdom

Location

Hampshire Hospitals NHS Foundation Trust

Basingstoke, United Kingdom

Location

University Hospitals Birmingham NHS Foundation Trust

Birmingham, United Kingdom

Location

Imperial College Healthcare NHS Trust

London, W68RF, United Kingdom

Location

Guy's and St Thomas' NHS Foundation Trust

London, United Kingdom

Location

Kings College Hospital NHS Foundation Trust

London, United Kingdom

Location

London North West University Healthcare NHS Trust

London, United Kingdom

Location

Royal Free London NHS Foundation Trust

London, United Kingdom

Location

East Cheshire NHS Trust

Macclesfield, United Kingdom

Location

The Newcastle Upon Tyne Hospitals NHS Foundation Trust

Newcastle, United Kingdom

Location

Barking, Havering and Redbridge University Hospitals NHS Trust

Romford, United Kingdom

Location

Salisbury Hospital NHS Foundation Trust

Salisbury, United Kingdom

Location

MeSH Terms

Conditions

Venous ThrombosisPostthrombotic Syndrome

Condition Hierarchy (Ancestors)

ThrombosisEmbolism and ThrombosisVascular DiseasesCardiovascular DiseasesVenous Insufficiency

Results Point of Contact

Title
Professor Alun Davies
Organization
Imperial College London

Study Officials

  • Alun H Davies

    Imperial College London

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
An independent researcher at each site will perform leg assessments blind to participant allocation. This researcher will not have been involved in recruitment, stocking provision, adherence monitoring or behavioural interventions. Participants will be encouraged to remove their stockings on the day prior to their clinic visit, they will be asked not to discuss the stockings with the independent assessor. Blinding will be assessed by asking the assessors whether the patient attended study visits wearing a stocking, and whether the patient made it known that they had been wearing a stocking or not.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 19, 2019

First Posted

September 25, 2019

Study Start

March 5, 2020

Primary Completion

December 31, 2022

Study Completion

December 31, 2022

Last Updated

March 7, 2024

Results First Posted

March 7, 2024

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations